Bio-Rad Laboratories (NYSE:BIO.B) Shares Cross Below 200 Day Moving Average – Here’s Why

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $324.63 and traded as low as $265.82. Bio-Rad Laboratories shares last traded at $265.82, with a volume of 11 shares trading hands.

Bio-Rad Laboratories Price Performance

The company has a current ratio of 6.48, a quick ratio of 4.85 and a debt-to-equity ratio of 0.18. The stock has a 50-day moving average price of $308.09 and a 200 day moving average price of $324.63. The stock has a market capitalization of $7.45 billion, a price-to-earnings ratio of -4.09 and a beta of 0.75.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its earnings results on Thursday, February 13th. The company reported $2.90 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 71.86%.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.